Freestone Grove Partners’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,144
Closed -$635K 1075
2026
Q1
$635K Buy
+10,144
New +$662K ﹤0.01% 560
2025
Q4
Sell
-185,008
Closed -$12.1M 765
2025
Q3
$12.1M Buy
+185,008
New +$13.6M 0.09% 270
2025
Q2
Sell
-92,164
Closed -$7.4M 701
2025
Q1
$7.4M Buy
+92,164
New +$7.86M 0.08% 257

Other funds holding CNS

Freestone Grove Partners's CNS Position: Q2 2026 in Review

Freestone Grove Partners sold out of Cohen & Steers (CNS) in Q2 2026, closing a stake of 10,144 shares — an estimated $635K sold.

Freestone Grove Partners first reported a position in CNS in Q1 2025 and held it in 3 quarters. The position peaked at $12.1M in Q3 2025. 311 funds tracked by Wall St. Rank hold CNS as of Q2 2026.

  • Freestone Grove Partners reported no remaining Cohen & Steers position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 10,144 Cohen & Steers shares in Q2 2026, an estimated $635K.
  • Freestone Grove Partners first reported a position in Cohen & Steers in Q1 2025 and held it in 3 quarters.
  • Freestone Grove Partners's Cohen & Steers position peaked at $12.1M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Cohen & Steers as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.